BNET Industries

Fast Track Systems Inc.

is in the Retail Industry

Last Fiscal Year Sales:$17.5M
  • Private
  • US
Dow Jones Description

As a world-class provider of clinical trial software and professional services to pharmaceutical and biotechnology companies, Fast Track Systems, Inc., provides a true competitive edge in the clinical development process. Whether authoring protocols; planning, negotiating, or managing trial budgets; seeking to drastically reduce trial cycle times; and/or needing to maintain strict fiscal responsibility, Fast Track has a customized solution to fit your needs. Fast Track's TrialSpace suite of products drive more robust and cost-effective clinical results by solving problems associated with trial design, review and start-up activities at the earliest stages of the clinical development process. Fast Track's global cost and procedure benchmarking databases; drawn from over 240,000 negotiated investigator agreements, 25,000 finalized protocols and 3,000 CRO contracts, have been the most relevant industry resource for over 14 years. Over 50 of the top pharmaceutical and biotech companies rely on our products and services to enable clinical researchers, finance staff and medical management to efficiently collaborate in making informed decisions that influence the execution of the final clinical plan.

Chief Technology Officer
Peter Abramowitsch
Number of Employees 34
Contact Information

227 Washington St Ste 310

Conshohocken, Pennsylvania 19428

fasttracksystem...

1 215 358 1400

NAICS Code Computer and Software Stores: 443120

News & Analysis

fast track systems inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Peter Abramowitsch Chief Technology Officer
Charlie Beitz Vice President of the Trialspace Designer Business Unit
Frank Cattie Vice President of Sales
Fredric Cohen Vice President of Clinical Strategy
Lori Shields Vice President of Operations

Board of Directors

Name (plus bio) Position
Alph Bingham Board of Directors
Alpheus Bingham Board of Directors
Scott Minick Board Director

Organization Position Status
Fast Track Systems Inc Chief Technology Officer Current

Charlie is responsible for the successful launch of TSD and establishing TSD as the market leading protocol design and clinical study execution solution to the Pharmaceutical/Biotechnology industry. Prior to his role at Fast Track Systems, Inc. Charlie worked for Documentum, e-Room and Liquent in a variety of executive roles. Each of these companies focuses entirely on or has a significant commitment to serving the technology needs of Pharmaceutical/Biotechnology industry. These experiences inform Charlie's broad knowledge of the issues facing the Pharmaceutical/Biotechnology industry and his insightful approach to tackling them. Charlie earned an MBA from the Fuqua School of Business at Duke University.

Organization Position Status
Fast Track Systems Inc Vice President of the Trialspace Designer Business Unit Current
Liquent, Inc. Former

Organization Position Status
Fast Track Systems Inc Vice President of Sales Current
Fast Track Systems Inc Sales Executive Current
La Salle University BS In Marketing Former

Organization Position Status
Fast Track Systems Inc Vice President of Clinical Strategy Current
Penn State College of Medicine Degree Former

Array

Organization Position Status
Fasttrack Current
Shippensburg University Former

Organization Position Status
Innocentive, Inc. Chief Executive Officer Current
Innocentive, Inc. Co-Founder Current
Business Innovation Factory Board of Directors Current
Fast Track Systems Inc Board of Directors Current
Innocentive, Inc. President Former
Eli Lilly and Company Former
The Editors Chairman of the Board Former
Stanford University Ph.D. In Organic Chemistry Former

Organization Position Status
TEDMED3 Vice President, Eli Lilly and Company Current
Innocentive, Inc. Founder and Member, Board of Directors Current
Innocentive, Inc. Chairman Current
TEDMED3 Board of Directors Current
Fast Track Systems Inc Board of Directors Current
The Editors Chairman of the Board Former
Stanford University Ph.D. In Organic Chemistry Former

Scott Minick is a Managing Director with ARCH, joining the firm as a Venture Partner in 1998. Mr. Minick has been instrumental in the startup, development and financing of numerous portfolio companies including XenoPort (XNPT), FastTrack Systems, MedVantx, Achaogen, Amphora Discovery, Celula, Ensemble Discovery, and Sorbent Therapeutics. He serves as a board director for Achaogen, Amphora Discovery, Celula, FastTrack Systems, Optobionics and Sorbent Therapeutics. Mr. Minick currently serves as Chairman of the Board for MedVantx and formerly served as Chairman of Xcyte Therapies (XCYT) through its IPO in 2004 and subsequent acquisition of Cyclacel Pharmaceuticals (CYCL). He also previously served as Executive Chairman of Amphora Discovery. From 1995 until 1998, Mr. Minick was director, President and COO of SEQUUS Pharmaceuticals, a public biopharmaceutical company that was acquired by GlaxoSmithKline. From 1994 to 1995, he served as a director, President and CEO of OncoTherapeutics, a private biotechnology company. Prior to that, Mr. Minick co-founded and was a director, President and CEO of LXR Biotechnology from startup through its IPO. From 1981 to 1993, he was an executive of Baxter Healthcare, holding leadership positions in the device, service and diagnostics businesses. He received his postgraduate training in neurobiology at the Salk Institute, an M.B.A. from Northwestern University and a B.A. with Honors from the University of California at San Diego.

Organization Position Status
Arch Venture Partners Managing Director Current
Achaogen Venture Partner Current
Amphora Discovery Corporation Venture Partner Current
Medvantx, Inc. Venture Partner Current
Vascular Architects, Inc. Observor Current
Trubion Pharmaceuticals, Inc Observor Current
Medvantx, Inc. Chairman of The Board Current
Cycl Chairman Current
Chiasma Inc. Board of Directors Current
C E L U L A, Inc Director Current
XenoPort Inc. Board of Directors Current
Amphora Discovery Corporation Board Member Current
Achaogen Board of Directors Current
BIND Biosciences, Inc. Board Director Current
Vascular Architects, Inc. Board of Directors Current
Optobionics Corporation Board Member Current
Fast Track Systems Inc Board Director Current
Trubion Pharmaceuticals, Inc Board of Directors Current
Arch Venture Partners Board of Directors Current
Oncotherapeutics, Inc. CEO Former
LXR Biotechnology, Inc. CEO Former
Oncotherapeutics, Inc. Interim President Former
SEQUUS Pharmaceuticals President Former
LXR Biotechnology, Inc. President Former
SEQUUS Pharmaceuticals Chief Operating Officer Former
LXR Biotechnology, Inc. co-founder Former
Arch Venture Partners Venture Partner Former
Ensemble Discovery Corporation Former
Amphora Discovery Corporation Executive Chairman Former
Cyclacel Pharmaceuticals, Inc. Chairman Former
SEQUUS Pharmaceuticals Director Former
Oncotherapeutics, Inc. Director Former
LXR Biotechnology, Inc. Director Former
Northwestern University M.B.A. Former
University of California, San Diego B.A. With Honors Former
University of California B.A. Former
Salk Institute Neurobiology Former
advertisement
Click Here
IndustryTop Rated
advertisement